Although there are controversial effectiveness signals with TNF inhibitors in improving chronic periodontitis [3,6,11,15,19,23,24,25,26,33,38,39], all papers about anti-IL-6 therapy clearly demonstrated articular, systemic, and also periodontal benefits with TCZ without any periodontal specific treatment [16,17,27,28]. This evidence concerns the gene IL6 and periodontitis.